Low dose naltrexone compounding

Low Dose Naltrexone

Low Dose Naltrexone (LDN)

LDN consultation

What Is Low Dose Naltrexone?

Naltrexone is a long-established medication. At its standard 50 mg dose, it's used in addiction medicine. “Low dose naltrexone,” or LDN, is the same medication prepared at a much smaller dose — usually somewhere between 1.5 mg and 4.5 mg per day.

Because the standard tablet is made for a different use and isn't designed to be split down to these small amounts, LDN is prepared by a compounding pharmacy. We make it to the exact strength your prescriber writes for you — as a capsule or a liquid.

Why Might a Prescriber Consider It?

Autoimmune & Inflammatory

LDN has drawn interest in the clinical research community as a possible adjunct in immune-related conditions. Published research and prescriber interest span areas such as:

  • Multiple sclerosis (MS)
  • Lupus (systemic lupus erythematosus)
  • Rheumatoid arthritis
  • Crohn's disease and ulcerative colitis
  • Hashimoto's thyroiditis
  • Psoriasis and psoriatic arthritis

The evidence is still emerging and differs by condition.

Chronic Pain and Fibromyalgia

LDN appears in published research on conditions that involve central sensitization and persistent pain. Areas studied in the literature include:

  • Fibromyalgia
  • Complex regional pain syndrome (CRPS)
  • Chronic fatigue syndrome (ME/CFS)
  • Long COVID and post-viral syndromes

This research is ongoing and varies by condition. Listing these areas isn't a claim that LDN is effective for them — its use is off-label, and whether it has a role for any patient is a decision for that patient and their prescriber.

Emerging Mental Health Applications

Early-stage research is also exploring LDN's potential role in mood regulation and neurological conditions, including:

  • Treatment-resistant depression
  • Autism spectrum disorder (ASD) — symptom management
  • PTSD and anxiety-related conditions
LDN dosing support

How LDN Dosing Works

LDN is almost always started at a low dose — often as low as 0.5 mg to 1.5 mg — and gradually titrated upward over weeks. This approach helps minimize initial side effects (most commonly, vivid dreams or mild sleep disturbance in the early weeks) and allows the prescribing clinician to find the therapeutic level that works best for each individual.

Because titration is essential to success, compounding pharmacies are uniquely suited to support LDN therapy: we can prepare capsules at any specific strength your prescriber designates throughout the titration process.

Why Voshell's for LDN?

Our compounded LDN formulations give prescribers the flexibility to meet diverse patient needs. Every strength is prepared fresh at our Baltimore pharmacy under USP-compliant standards, with pharmacist support available for prescriber questions on dosing and titration.

Precise dosing

Capsules compounded to the exact strength your prescriber orders, from 0.1 mg to 4.5 mg.

Flexible strengths

Common prescribed strengths — 0.1, 0.5, 1.5, 2, 3, and 4.5 mg — or any dose in between, exactly as written.

Micro-dosing support

customized ultra-low starting doses for sensitive patients or complex titration plans

Supply options

30-, 60-, and 90-count quantities prepared per prescription to support ongoing care.

What to Expect

What to Expect From Your LDN Compound

At Voshell's Pharmacy, LDN is most commonly prepared as:

  • Capsules: the most common delivery form, prepared at the exact prescribed strength
  • Liquid formulations: useful for very fine dose adjustments during titration or for patients who cannot swallow capsules

We prepare each batch with careful attention to uniformity and dose accuracy — because with LDN, small differences in dose matter.

whether LDN fits your care plan

LDN compounded medication

Compliance Note

LDN is prescribed off-label for most of the conditions discussed above. Compounded LDN is not FDA-approved and has not been evaluated by the FDA for safety or effectiveness. All LDN therapy requires a valid prescription from a licensed prescriber. Clinical evidence varies by condition and continues to evolve, and compounded medications may not be appropriate for all patients.